|
Name |
Isoterpinolene
|
| Molecular Formula | C10H16 | |
| IUPAC Name* |
3-methyl-6-propan-2-ylidenecyclohexene
|
|
| SMILES |
CC1CCC(=C(C)C)C=C1
|
|
| InChI |
InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,6,9H,5,7H2,1-3H3
|
|
| InChIKey |
CIPXOBMYVWRNLL-UHFFFAOYSA-N
|
|
| Synonyms |
Isoterpinolene; 586-63-0; p-Mentha-2,4(8)-diene; 3-Methyl-6-(1-methylethylidene)cyclohexene; 2,4(8)-p-Menthadiene; Cyclohexene, 3-methyl-6-(1-methylethylidene)-; 3-methyl-6-propan-2-ylidenecyclohexene; VR4XVW6V2H; EINECS 209-579-6; UNII-VR4XVW6V2H; p-2,4(8)-Menthadiene; para-Mentha-2,4(8)-diene; CHEBI:88840; DTXSID80862244; 3-Isopropylidene-6-methyl-cyclohexene; 3-Methyl-6-(1-methylethylidene)-cyclohexene; 3-Methyl-6-(1-methylethylidene)-1-cyclohexene #; Q24514387
|
|
| CAS | 586-63-0 | |
| PubChem CID | 102443 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 136.23 | ALogp: | 3.5 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.471 |
| Caco-2 Permeability: | -4.403 | MDCK Permeability: | 0.00001900 |
| Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.008 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.021 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.374 | Plasma Protein Binding (PPB): | 93.03% |
| Volume Distribution (VD): | 3.917 | Fu: | 6.50% |
| CYP1A2-inhibitor: | 0.427 | CYP1A2-substrate: | 0.585 |
| CYP2C19-inhibitor: | 0.148 | CYP2C19-substrate: | 0.915 |
| CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.493 |
| CYP2D6-inhibitor: | 0.274 | CYP2D6-substrate: | 0.891 |
| CYP3A4-inhibitor: | 0.088 | CYP3A4-substrate: | 0.579 |
| Clearance (CL): | 11.686 | Half-life (T1/2): | 0.692 |
| hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.431 |
| Drug-inuced Liver Injury (DILI): | 0.117 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.061 | Maximum Recommended Daily Dose: | 0.747 |
| Skin Sensitization: | 0.928 | Carcinogencity: | 0.84 |
| Eye Corrosion: | 0.603 | Eye Irritation: | 0.935 |
| Respiratory Toxicity: | 0.928 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001082 | ![]() |
0.333 | D0F1UL | ![]() |
0.197 | ||
| ENC002403 | ![]() |
0.317 | D0K7LU | ![]() |
0.188 | ||
| ENC002234 | ![]() |
0.308 | D0W6DG | ![]() |
0.181 | ||
| ENC000383 | ![]() |
0.286 | D0O1UZ | ![]() |
0.169 | ||
| ENC000395 | ![]() |
0.286 | D0H1QY | ![]() |
0.167 | ||
| ENC001813 | ![]() |
0.283 | D0WO8W | ![]() |
0.167 | ||
| ENC000965 | ![]() |
0.273 | D04CSZ | ![]() |
0.167 | ||
| ENC001825 | ![]() |
0.259 | D0P0HT | ![]() |
0.165 | ||
| ENC002138 | ![]() |
0.259 | D0TY5N | ![]() |
0.164 | ||
| ENC002860 | ![]() |
0.256 | D01JMC | ![]() |
0.164 | ||